表紙:咳嗽性過敏症症候群の世界市場レポート 2024年
市場調査レポート
商品コード
1415736

咳嗽性過敏症症候群の世界市場レポート 2024年

Cough Hypersensitivity Syndrome Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
咳嗽性過敏症症候群の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

咳嗽性過敏症症候群市場規模は近年力強く成長しています。2023年の97億1,000万米ドルから2024年には103億6,000万米ドルに、CAGR6.8%で拡大します。実績期間の成長は、認知度の向上、遠隔医療と遠隔モニタリング、公衆衛生への取り組み、研究資金に起因します。

タバコを吸う人の増加は、当面の咳嗽性過敏症症候群市場の拡大を推進する重要な要因になると予測されます。紙巻きタバコの喫煙者は、紙巻きタバコの葉を燃やして発生する煙を吸引することで、定期的に紙巻きタバコを喫煙する個人です。タバコは、気道に刺激を与え、炎症を誘発し、肺組織に損傷を与えることによって、咳嗽性過敏症症候群を誘発します。例えば、2022年7月現在、カナダ統計局は2021年6月と比較してタバコの生産量が5.8%増加したと報告しています。さらに、タバコの総販売本数は1.3%増加し、2022年6月には14億本に達しました。さらに、2023年5月、米国疾病予防管理センターは、推定2,830万人の米国成人がたばこ喫煙者であり、約308万人の米国中高生が少なくとも1つのたばこ製品を使用していることを明らかにしました。毎日、約1,600人の18歳以下の米国青少年が最初のタバコを試しています。したがって、タバコを吸う人口の増加が咳嗽性過敏症症候群市場の成長を牽引すると予想されます。

2023年の咳嗽性過敏症症候群市場で最大の地域は北米です。咳嗽性過敏症症候群レポートがカバーする地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の咳嗽性過敏症症候群市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の咳嗽性過敏症症候群の市場規模実績と成長、2018~2023年
  • 世界の咳嗽性過敏症症候群市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の咳嗽性過敏症症候群市場、薬剤クラス別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • コルチコステロイド吸入
  • 鎮咳嗽性薬
  • 短時間作用型β2アゴニスト
  • 抗コリン薬
  • プロトンポンプ阻害剤
  • 抗ヒスタミン薬
  • その他
  • 世界の咳嗽性過敏症症候群市場、投与経路別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 経口
  • 吸入
  • その他
  • 世界の咳嗽性過敏症症候群市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院
  • 専門クリニック
  • 在宅医療
  • その他

第7章 地域と国の分析

  • 世界の咳嗽性過敏症症候群市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の咳嗽性過敏症症候群市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 咳嗽性過敏症症候群市場の競合情勢
  • 咳嗽性過敏症症候群市場の企業プロファイル
    • Pfizer Inc.
    • Johnson and Johnson Ltd.
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • Novartis AG

第31章 その他の主要と革新的な企業

  • Merck and Co Inc.
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • AstraZeneca Plc.
  • GlaxoSmithKline Plc
  • Takeda Pharmaceutical Company Limited
  • Boehringer Ingelheim GmbH
  • Wyeth Pharmaceuticals Inc.
  • AstraZeneca Pharmaceuticals LP
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Lupin Limited
  • Cadila Pharmaceuticals
  • Almirall S.A.
  • Akorn Operating Company LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r12335

“Cough Hypersensitivity Syndrome Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cough hypersensitivity syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cough hypersensitivity syndrome? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cough hypersensitivity syndrome market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drug Class: Inhales Corticosteroids; Antitussive Agents; Short-acting Beta-2 Agonists; Anticholinergics; Proton Pump Inhibitors; Antihistamines; Other Drugs
  • 2) By Route of Administration: Oral; Inhalation; Other Route Of Administration
  • 3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
  • Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; F. Hoffmann-La Roche AG; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cough hypersensitivity syndrome (CHS) is a medical condition characterized by an exaggerated and abnormal response of the cough reflex to various stimuli, often leading to persistent and chronic coughing. It is commonly associated with conditions such as asthma, gastroesophageal reflux disease (GERD), and upper airway disorders.

The main drug types used for treating cough hypersensitivity syndrome include inhaled corticosteroids, antitussive agents, short-acting beta-2 agonists, anticholinergics, proton pump inhibitors, antihistamines, and others. Inhaled corticosteroids (ICS) refer to a class of medications used in the treatment of various respiratory conditions. These drugs can be administered orally, through inhalation, or by other means. They are utilized by various end-users, including hospitals, specialty clinics, homecare services, and others.

The cough hypersensitivity syndrome market research report is one of a series of new reports from The Business Research Company that provides cough hypersensitivity syndrome market statistics, including cough hypersensitivity syndrome industry global market size, regional shares, competitors with a cough hypersensitivity syndrome market share, detailed cough hypersensitivity syndrome market segments, market trends and opportunities and any further data you may need to thrive in the cough hypersensitivity syndrome industry. This cough hypersensitivity syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $9.71 billion in 2023 to $10.36 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased awareness, telemedicine and remote monitoring, public health initiatives, research funding.

The cough hypersensitivity syndrome market size is expected to see strong growth in the next few years. It will grow to $13.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to global health access, patient advocacy and support, quality of life improvements. Major trends in the forecast period include improved diagnosis and screening tools, personalized treatment approaches, new medications.

The increasing prevalence of chronic respiratory diseases is anticipated to be a significant driver for the growth of the cough hypersensitivity syndrome market in the coming years. Chronic respiratory diseases (CRDs) encompass a range of long-term conditions affecting the airways and lungs, resulting in ongoing breathing difficulties and a gradual decline in lung function. Treatment for cough hypersensitivity syndrome aims to alleviate discomfort and improve respiratory health, ultimately enhancing the quality of life for individuals grappling with chronic respiratory conditions like asthma. For instance, as of June 2023, the Australian Institute of Health and Welfare reports that nearly 30% of the Australian population, equivalent to 7.5 million individuals, are contending with chronic respiratory diseases. Furthermore, in the same period, the Centers for Disease Control and Prevention noted 142,342 deaths attributed to chronic lower respiratory diseases in 2021 in the United States. Consequently, the growing prevalence of chronic respiratory diseases serves as a driving force behind the expansion of the cough hypersensitivity syndrome market.

The increasing population of cigarette smokers is anticipated to be a significant factor propelling the expansion of the cough hypersensitivity syndrome market in the foreseeable future. Cigarette smokers are individuals who regularly engage in tobacco use by smoking cigarettes, involving the inhalation of smoke generated from burning tobacco leaves encased in a paper-wrapped cylinder. Cigarette smoking induces cough hypersensitivity syndrome by provoking irritation in the airways, inciting inflammation, and causing damage to lung tissues. For instance, as of July 2022, Statistics Canada reported a 5.8% increase in cigarette production compared to June 2021. Additionally, the total number of cigarettes sold rose by 1.3%, reaching 1.4 billion in June 2022. Furthermore, in May 2023, the Centers for Disease Control and Prevention revealed that an estimated 28.3 million U.S. adults are cigarette smokers, with about 3.08 million U.S. middle and high school students using at least one tobacco product. Each day, approximately 1,600 U.S. youth under the age of 18 try their first cigarette. Therefore, the growing population of cigarette smokers is expected to drive the growth of the cough hypersensitivity syndrome market.

Drug abuse is anticipated to have an adverse effect on the growth of the cough hypersensitivity syndrome market in the coming years. The misuse of these substances can lead to dependency, abuse, or the occurrence of central side effects. While drugs like morphine and diamorphine can be highly effective in alleviating severe and distressing coughs in patients with terminal illnesses such as cough hypersensitivity syndrome, they also carry a risk of addiction. For instance, as of June 2022, Springer Nature Limited reported an increase in the use of antitussive agents for cough hypersensitivity syndrome. Some of these agents, including codeine and hydrocodone, belong to the opioid class of drugs, which have the potential to lead to addiction and substance use disorder. Consequently, drug abuse is expected to negatively impact the growth of the cough hypersensitivity syndrome market.

Leading companies in the cough hypersensitivity syndrome market are embracing AI-powered algorithms to drive innovation and maintain their competitive edge. These algorithms harness the power of artificial intelligence (AI) to execute tasks and tackle challenges in an efficient and effective manner. For instance, in April 2021, NuvoAir, a US-based digital healthcare company, unveiled the NuvoAir Cough mobile application designed for detecting cough hypersensitivity syndrome. This innovative smartphone app is compatible with the iOS operating system and employs the device's microphone along with an AI-powered algorithm to discern and record coughs within domestic environments. The algorithm distinguishes coughs from other ambient sounds, providing the results to both the user and their attending physician.

In June 2023, GlaxoSmithKline PLC, a prominent UK-based pharmaceutical and biotechnology company specializing in the production of drugs for cough hypersensitivity syndrome, completed the acquisition of Bellus Health Inc. for $2.0 billion. Through this strategic move, GSK aims to bolster its array of respiratory medications, as well as enhance its capabilities in research and development, production, and commercialization. Bellus Health Inc. is a biotechnology company based in Canada, known for its development of drugs tailored for cough hypersensitivity syndrome.

Major players in the cough hypersensitivity syndrome market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck and Co Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Wyeth Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Mylan N.V., Lupin Limited, Cadila Pharmaceuticals, Almirall S.A., Akorn Operating Company LLC, Kudco Ireland Ltd., Prestige Consumer Healthcare Inc., GMP Laboratories of America Inc., The Betty Mills Company, Acura Pharmaceuticals Inc.

North America was the largest region in the cough hypersensitivity syndrome market in 2023. The regions covered in cough hypersensitivity syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cough hypersensitivity syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cough hypersensitivity syndrome market consists of sales of cough suppressants, steam inhalers and humidifiers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Cough Hypersensitivity Syndrome Market Characteristics

3. Cough Hypersensitivity Syndrome Market Trends And Strategies

4. Cough Hypersensitivity Syndrome Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cough Hypersensitivity Syndrome Market Size and Growth

  • 5.1. Global Cough Hypersensitivity Syndrome Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cough Hypersensitivity Syndrome Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cough Hypersensitivity Syndrome Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cough Hypersensitivity Syndrome Market Segmentation

  • 6.1. Global Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inhales Corticosteroids
  • Antitussive Agents
  • Short-acting Beta-2 Agonists
  • Anticholinergics
  • Proton Pump Inhibitors
  • Antihistamines
  • Other Drugs
  • 6.2. Global Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Inhalation
  • Other Route Of Administration
  • 6.3. Global Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Other End-Users

7. Cough Hypersensitivity Syndrome Market Regional And Country Analysis

  • 7.1. Global Cough Hypersensitivity Syndrome Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cough Hypersensitivity Syndrome Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cough Hypersensitivity Syndrome Market

  • 8.1. Asia-Pacific Cough Hypersensitivity Syndrome Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cough Hypersensitivity Syndrome Market

  • 9.1. China Cough Hypersensitivity Syndrome Market Overview
  • 9.2. China Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cough Hypersensitivity Syndrome Market

  • 10.1. India Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cough Hypersensitivity Syndrome Market

  • 11.1. Japan Cough Hypersensitivity Syndrome Market Overview
  • 11.2. Japan Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cough Hypersensitivity Syndrome Market

  • 12.1. Australia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cough Hypersensitivity Syndrome Market

  • 13.1. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cough Hypersensitivity Syndrome Market

  • 14.1. South Korea Cough Hypersensitivity Syndrome Market Overview
  • 14.2. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cough Hypersensitivity Syndrome Market

  • 15.1. Western Europe Cough Hypersensitivity Syndrome Market Overview
  • 15.2. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cough Hypersensitivity Syndrome Market

  • 16.1. UK Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cough Hypersensitivity Syndrome Market

  • 17.1. Germany Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cough Hypersensitivity Syndrome Market

  • 18.1. France Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cough Hypersensitivity Syndrome Market

  • 19.1. Italy Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cough Hypersensitivity Syndrome Market

  • 20.1. Spain Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cough Hypersensitivity Syndrome Market

  • 21.1. Eastern Europe Cough Hypersensitivity Syndrome Market Overview
  • 21.2. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cough Hypersensitivity Syndrome Market

  • 22.1. Russia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cough Hypersensitivity Syndrome Market

  • 23.1. North America Cough Hypersensitivity Syndrome Market Overview
  • 23.2. North America Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cough Hypersensitivity Syndrome Market

  • 24.1. USA Cough Hypersensitivity Syndrome Market Overview
  • 24.2. USA Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cough Hypersensitivity Syndrome Market

  • 25.1. Canada Cough Hypersensitivity Syndrome Market Overview
  • 25.2. Canada Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cough Hypersensitivity Syndrome Market

  • 26.1. South America Cough Hypersensitivity Syndrome Market Overview
  • 26.2. South America Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cough Hypersensitivity Syndrome Market

  • 27.1. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cough Hypersensitivity Syndrome Market

  • 28.1. Middle East Cough Hypersensitivity Syndrome Market Overview
  • 28.2. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cough Hypersensitivity Syndrome Market

  • 29.1. Africa Cough Hypersensitivity Syndrome Market Overview
  • 29.2. Africa Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cough Hypersensitivity Syndrome Market Competitive Landscape And Company Profiles

  • 30.1. Cough Hypersensitivity Syndrome Market Competitive Landscape
  • 30.2. Cough Hypersensitivity Syndrome Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson and Johnson Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cough Hypersensitivity Syndrome Market Other Major And Innovative Companies

  • 31.1. Merck and Co Inc.
  • 31.2. Sanofi S.A.
  • 31.3. Bristol-Myers Squibb Company
  • 31.4. AstraZeneca Plc.
  • 31.5. GlaxoSmithKline Plc
  • 31.6. Takeda Pharmaceutical Company Limited
  • 31.7. Boehringer Ingelheim GmbH
  • 31.8. Wyeth Pharmaceuticals Inc.
  • 31.9. AstraZeneca Pharmaceuticals LP
  • 31.10. Teva Pharmaceutical Industries Ltd.
  • 31.11. Mylan N.V.
  • 31.12. Lupin Limited
  • 31.13. Cadila Pharmaceuticals
  • 31.14. Almirall S.A.
  • 31.15. Akorn Operating Company LLC

32. Global Cough Hypersensitivity Syndrome Market Competitive Benchmarking

33. Global Cough Hypersensitivity Syndrome Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cough Hypersensitivity Syndrome Market

35. Cough Hypersensitivity Syndrome Market Future Outlook and Potential Analysis

  • 35.1 Cough Hypersensitivity Syndrome Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cough Hypersensitivity Syndrome Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cough Hypersensitivity Syndrome Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer